Arioron's Breakthrough: OncoDetect Titan Surpasses Benchmarks, Redefining Cancer AI
Arioron's OncoDetect Titan has achieved a groundbreaking 100% sensitivity in lung cancer detection on an external test dataset, surpassing Google Health's 94.4% on the same international benchmark. This breakthrough stems from a unique multi-model 'Council of Six' approach, engineered to thrive on real-world, inconsistent hospital data, not just controlled lab environments. Designed with emerging markets in mind, OncoDetect Titan aims to democratize early cancer detection and reduce misdiagnosis globally, moving from benchmarks to bedside impact....
Read Article